Mehul Suthar to Pandemics
This is a "connection" page, showing publications Mehul Suthar has written about Pandemics.
Connection Strength
0.025
-
Development of a Rapid Focus Reduction Neutralization Test Assay for Measuring SARS-CoV-2 Neutralizing Antibodies. Curr Protoc Immunol. 2020 12; 131(1):e116.
Score: 0.008
-
Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures. J Virol. 2020 09 15; 94(19).
Score: 0.008
-
Prevalence of SARS-CoV-2 antibodies in pediatric healthcare workers. Int J Infect Dis. 2021 Apr; 105:474-481.
Score: 0.002
-
Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India. Virology. 2021 06; 558:13-21.
Score: 0.002
-
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity. Nat Commun. 2020 11 26; 11(1):6013.
Score: 0.002
-
Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation. Nat Commun. 2020 10 27; 11(1):5413.
Score: 0.002
-
COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease. Blood Adv. 2020 09 22; 4(18):4278-4281.
Score: 0.002